Next Article in Journal
Incomplete Penetrance and Variable Expressivity: Hallmarks in Channelopathies Associated with Sudden Cardiac Death
Next Article in Special Issue
Interaction Analysis of Longevity Interventions Using Survival Curves
Previous Article in Journal
Was the Watchmaker Blind? Or Was She One-Eyed?
Previous Article in Special Issue
Stability of Signaling Pathways during Aging—A Boolean Network Approach
Open AccessFeature PaperArticle

Age-Dependence and Aging-Dependence: Neuronal Loss and Lifespan in a C. elegans Model of Parkinson’s Disease

by Javier Apfeld 1,* and Walter Fontana 2,*
Biology Department, Northeastern University, Boston, MA 02115, USA
Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
Authors to whom correspondence should be addressed.
Received: 23 November 2017 / Revised: 16 December 2017 / Accepted: 18 December 2017 / Published: 23 December 2017
(This article belongs to the Special Issue Systems Biology of Aging)
It is often assumed, but not established, that the major neurodegenerative diseases, such as Parkinson’s disease, are not just age-dependent (their incidence changes with time) but actually aging-dependent (their incidence is coupled to the process that determines lifespan). To determine a dependence on the aging process requires the joint probability distribution of disease onset and lifespan. For human Parkinson’s disease, such a joint distribution is not available, because the disease cuts lifespan short. To acquire a joint distribution, we resorted to an established C. elegans model of Parkinson’s disease in which the loss of dopaminergic neurons is not fatal. We find that lifespan is not correlated with the loss of individual neurons. Therefore, neuronal loss is age-dependent and aging-independent. We also find that a lifespan-extending intervention into insulin/IGF1 signaling accelerates the loss of specific dopaminergic neurons, while leaving death and neuronal loss times uncorrelated. This suggests that distinct and compartmentalized instances of the same genetically encoded insulin/IGF1 signaling machinery act independently to control neurodegeneration and lifespan in C. elegans. Although the human context might well be different, our study calls attention to the need to maintain a rigorous distinction between age-dependence and aging-dependence. View Full-Text
Keywords: C. elegans; Parkinson’s disease; disease of aging C. elegans; Parkinson’s disease; disease of aging
Show Figures

Figure 1

MDPI and ACS Style

Apfeld, J.; Fontana, W. Age-Dependence and Aging-Dependence: Neuronal Loss and Lifespan in a C. elegans Model of Parkinson’s Disease. Biology 2018, 7, 1.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop